{"transactions":[{"id":2906899,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":1511966,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These securities are owned directly by F2 MC, LLC (\"F2 MC\"). Globeways II is the appointed manager of F2 MC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":214798},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906898,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":503988,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are owned directly by F2 Bio TD, LLC (\"F2 Bio\"). Globeways II is the appointed manager of F2 Bio. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bio. . The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71599},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906897,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":1007977,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by F2 MG Limited (\"F2 MG\"). Globeways is the appointed manager of F2 MG. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":143198},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906896,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":503988,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by F2-TPO Investments, LLC (\"F2-TPO\"). Globeways Holdings II Limited (\"Globeways II\") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71599},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906895,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":1282051,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by F2 MG Limited (\"F2 MG\"). Globeways is the appointed manager of F2 MG. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":182135},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906894,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":3205128,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by F2-TPO Investments, LLC (\"F2-TPO\"). Globeways Holdings II Limited (\"Globeways II\") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":455338},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906893,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":4500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by F2 Bioscience I 2017 Limited (\"F2 Bioscience 2017\"). Globeways is the appointed manager of F2 Bioscience 2017. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":639295},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906892,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":20500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by F2 Vision SCS (\"F2 Vision\"). F2 Vision Management Sarl (\"F2 Vision Management\") is the appointed manager of F2 Vision. The Reporting Person is the founding director of F2 Vision Management and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Vision. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2912345},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906891,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Convertible Preferred Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":8000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by Globeways Holdings Limited (\"Globeways\"). The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by Globeways. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1136525},"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906890,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"purchase","acquired":true,"shares":104762,"price":21,"value":2200002.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"These securities are owned directly by F2 GC LLC (\"F2 GC\"). Globeways II is the appointed manager of F2 GC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 GC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":104762,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906889,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"purchase","acquired":true,"shares":95238,"price":21,"value":1999998.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by F2-TPO Investments, LLC (\"F2-TPO\"). Globeways Holdings II Limited (\"Globeways II\") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":622175,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906888,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":214798,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These securities are owned directly by F2 MC, LLC (\"F2 MC\"). Globeways II is the appointed manager of F2 MC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":214798,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906887,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":71599,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are owned directly by F2 Bio TD, LLC (\"F2 Bio\"). Globeways II is the appointed manager of F2 Bio. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bio. . The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":71599,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906886,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":143198,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by F2 MG Limited (\"F2 MG\"). Globeways is the appointed manager of F2 MG. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":325333,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906885,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":71599,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by F2-TPO Investments, LLC (\"F2-TPO\"). Globeways Holdings II Limited (\"Globeways II\") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":526937,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906884,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":182135,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by F2 MG Limited (\"F2 MG\"). Globeways is the appointed manager of F2 MG. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":182135,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906883,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":455338,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by F2-TPO Investments, LLC (\"F2-TPO\"). Globeways Holdings II Limited (\"Globeways II\") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":455338,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906882,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":639295,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by F2 Bioscience I 2017 Limited (\"F2 Bioscience 2017\"). Globeways is the appointed manager of F2 Bioscience 2017. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":639295,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906881,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":2912345,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by F2 Vision SCS (\"F2 Vision\"). F2 Vision Management Sarl (\"F2 Vision Management\") is the appointed manager of F2 Vision. The Reporting Person is the founding director of F2 Vision Management and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Vision. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2912345,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":2906880,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124886,"kind":"person","name":"F2 Vision SCS","position":3,"cik":"0001838409","reported_name":"F2 Vision SCS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125896,"kind":"organization","name":"F2 Bioscience I 2017 Ltd","position":4,"cik":"0001838573","reported_name":"F2 Bioscience I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":5,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":6,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143778,"kind":"organization","name":"F2 Bio TD, LLC","position":7,"cik":"0001838330","reported_name":"F2 Bio TD, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124860,"kind":"person","name":"F2 MC, LLC","position":8,"cik":"0001838426","reported_name":"F2 MC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":143779,"kind":"organization","name":"F2 GC, LLC","position":9,"cik":"0001840637","reported_name":"F2 GC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T22:30:41.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":1136525,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the \"Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021.  The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by Globeways Holdings Limited (\"Globeways\"). The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by Globeways. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1136525,"source":{"system":"sec-edgar","filing":"0000899243-21-002048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1575745/000089924321002048/doc4.xml","form_type":"4"}},{"id":3334797,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":7,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T17:31:30.000Z","date":"2019-12-20","kind":"other","acquired":false,"shares":13847,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata in-kind distribution of common stock by F2 BBG LLC without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":161024,"source":{"system":"sec-edgar","filing":"0000899243-19-029791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319029791/doc4.xml","form_type":"4"}},{"id":3334796,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":7,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T17:31:30.000Z","date":"2019-12-20","kind":"other","acquired":false,"shares":586153,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of common stock by F2 Capital I 2015 Limited without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":713723,"source":{"system":"sec-edgar","filing":"0000899243-19-029791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319029791/doc4.xml","form_type":"4"}},{"id":3334795,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":7,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T17:31:30.000Z","date":"2019-12-19","kind":"sale","acquired":false,"shares":35323,"price":16.4714,"value":581819.2622,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":155986,"source":{"system":"sec-edgar","filing":"0000899243-19-029791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319029791/doc4.xml","form_type":"4"}},{"id":3334794,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":7,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T17:31:30.000Z","date":"2019-12-19","kind":"sale","acquired":false,"shares":6642,"price":16.4714,"value":109403.0388,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":82575,"source":{"system":"sec-edgar","filing":"0000899243-19-029791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319029791/doc4.xml","form_type":"4"}},{"id":3334793,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":7,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T17:31:30.000Z","date":"2019-12-18","kind":"sale","acquired":false,"shares":2433,"price":17.006,"value":41375.598,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":191309,"source":{"system":"sec-edgar","filing":"0000899243-19-029791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319029791/doc4.xml","form_type":"4"}},{"id":3334792,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":7,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-20T17:31:30.000Z","date":"2019-12-18","kind":"sale","acquired":false,"shares":458,"price":17.006,"value":7788.748,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":89217,"source":{"system":"sec-edgar","filing":"0000899243-19-029791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319029791/doc4.xml","form_type":"4"}},{"id":3345419,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":4153,"price":17.6525,"value":73310.8325,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1299876,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345418,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":1054,"price":17.6525,"value":18605.735,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":330238,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345417,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":1381,"price":17.6525,"value":24378.1025,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2-TPO Investments, LLC. Globeways Holdings II Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":432319,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345416,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":1155,"price":17.6525,"value":20388.6375,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":361665,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345415,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":30475,"price":17.6232,"value":537067.02,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1304029,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345414,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":7741,"price":17.6232,"value":136421.1912,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":331292,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345413,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":10135,"price":17.6232,"value":178611.132,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2-TPO Investments, LLC. Globeways Holdings II Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":433700,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345412,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":8479,"price":17.6232,"value":149427.1128,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":362820,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345411,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":75067,"price":17.6511,"value":1325015.1237,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1334504,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345410,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":19070,"price":17.6511,"value":336606.477,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":339033,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345409,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":24966,"price":17.6511,"value":440677.3626,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2-TPO Investments, LLC. Globeways Holdings II Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":443835,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3345408,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T19:09:41.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":20886,"price":17.6511,"value":368660.8746,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":371299,"source":{"system":"sec-edgar","filing":"0000899243-19-028968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319028968/doc4.xml","form_type":"4"}},{"id":3388722,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-10-24T18:36:30.000Z","date":"2019-10-22","kind":"sale","acquired":false,"shares":2085,"price":15.1571,"value":31602.5535,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1409571,"source":{"system":"sec-edgar","filing":"0000899243-19-025909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319025909/doc4.xml","form_type":"4"}},{"id":3388721,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-10-24T18:36:30.000Z","date":"2019-10-22","kind":"sale","acquired":false,"shares":530,"price":15.1571,"value":8033.263,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":358103,"source":{"system":"sec-edgar","filing":"0000899243-19-025909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319025909/doc4.xml","form_type":"4"}},{"id":3388720,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-10-24T18:36:30.000Z","date":"2019-10-22","kind":"sale","acquired":false,"shares":693,"price":15.1571,"value":10503.8703,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2-TPO Investments, LLC. Globeways Holdings II Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":392185,"source":{"system":"sec-edgar","filing":"0000899243-19-025909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319025909/doc4.xml","form_type":"4"}},{"id":3388719,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-10-24T18:36:30.000Z","date":"2019-10-22","kind":"sale","acquired":false,"shares":580,"price":15.1571,"value":8791.118,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":392185,"source":{"system":"sec-edgar","filing":"0000899243-19-025909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319025909/doc4.xml","form_type":"4"}},{"id":3407145,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":5516,"price":17.3114,"value":95489.6824,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1411656,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407144,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":1401,"price":17.3114,"value":24253.2714,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":358633,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407143,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":1835,"price":17.3114,"value":31766.419,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":469464,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407142,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":351,"price":17.3114,"value":6076.3014,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":89675,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407141,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":683,"price":17.3114,"value":11823.6862,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":174871,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407140,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":1535,"price":17.3114,"value":26572.999,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":392765,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407139,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":197343,"price":17.9354,"value":3539425.6422,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1417172,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407138,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":50134,"price":17.9354,"value":899173.3436,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":360034,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407137,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":65633,"price":17.9354,"value":1177154.1082,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":471299,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407136,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":12537,"price":17.9354,"value":224856.1098,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":90026,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407135,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":24446,"price":17.9354,"value":438448.7884,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":175554,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3407134,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":5,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":6,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":7,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":8,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":9,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-24T20:27:35.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":54907,"price":17.9354,"value":984779.0078,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director and shareholder of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":394300,"source":{"system":"sec-edgar","filing":"0000899243-19-024208","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750019/000089924319024208/doc4.xml","form_type":"4"}},{"id":3643995,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":2500000,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":403629},"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643994,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":1750000,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":282540},"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643993,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":2540500,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":410168},"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643992,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":1200000,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":193742},"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643991,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":false,"shares":10000001,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1614515},"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643990,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"purchase","acquired":true,"shares":133333,"price":15,"value":1999995.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":536962,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643989,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"purchase","acquired":true,"shares":166667,"price":15,"value":2500005.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":449207,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643988,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"purchase","acquired":true,"shares":166667,"price":15,"value":2500005.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The reported securities are owned directly by F2 Capital I 2019, LLC. Globeways Holdings II Limited is the appointed manager of F2 Capital I 2019, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2019, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":166667,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643987,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"purchase","acquired":true,"shares":200000,"price":15,"value":3000000.0,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"The reported securities are owned directly by F2 BBG LLC. Globeways Holdings II Limited is the appointed manager of F2 BBG LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 BBG LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings II Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643986,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":403629,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The reported securities are owned directly F2-TPO Investments, LLC. Globeways Holdings Limited is the appointed manager of F2-TPO Investments, LLC and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO Investments, LLC. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":403629,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643985,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":282540,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities are owned directly by F2 MG Limited. Globeways Holdings Limited is the appointed manager of F2 MG Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":282540,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643984,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":410168,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reported securities are owned directly by F2 Capital I 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":410168,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643983,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":193742,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are owned directly by F2 Bioscience II 2017 Limited. Globeways Holdings Limited is the appointed manager of F2 Bioscience II 2017 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience II 2017 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":193742,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}},{"id":3643982,"issuer":{"id":94327,"kind":"organization","name":"TCR2 THERAPEUTICS INC.","symbol":"TCRR"},"owners":[{"id":41364,"kind":"person","name":"Jovan-Embiricos Morana","position":1,"cik":"0001575745","reported_name":"Jovan-Embiricos Morana","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124858,"kind":"person","name":"Globeways Holdings Ltd","position":2,"cik":"0001600769","reported_name":"Globeways Holdings Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124863,"kind":"person","name":"Globeways Holdings II Ltd","position":3,"cik":"0001768161","reported_name":"Globeways Holdings II Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152990,"kind":"organization","name":"F2 Capital I 2015 Ltd","position":4,"cik":"0001767391","reported_name":"F2 Capital I 2015 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152992,"kind":"organization","name":"F2 Bioscience II 2017 Ltd","position":5,"cik":"0001767388","reported_name":"F2 Bioscience II 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152991,"kind":"organization","name":"F2 Captial I 2017 Ltd","position":6,"cik":"0001767390","reported_name":"F2 Captial I 2017 Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124857,"kind":"person","name":"F2 MG Ltd","position":7,"cik":"0001767396","reported_name":"F2 MG Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124859,"kind":"person","name":"F2 - TPO Investments LLC","position":8,"cik":"0001767397","reported_name":"F2 - TPO Investments LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152993,"kind":"organization","name":"F2 BBG LLC","position":9,"cik":"0001767415","reported_name":"F2 BBG LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":152994,"kind":"organization","name":"F2 Capital I 2019, LLC","position":10,"cik":"0001767418","reported_name":"F2 Capital I 2019, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-02-21T17:01:11.000Z","date":"2019-02-19","kind":"exercise","acquired":true,"shares":1614515,"ownership":{"direct":false,"nature":"By Fund"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 (\"Common Stock\"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are owned directly by F2 Capital I 2015 Limited. Globeways Holdings Limited is the appointed manager of F2 Capital I 2015 Limited and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Capital I 2015 Limited. Morana Jovan-Embiricos is the founding director of Globeways Holdings Limited and has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein."}],"balance_after":1614515,"source":{"system":"sec-edgar","filing":"0000899243-19-004404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1767388/000089924319004404/doc4.xml","form_type":"4"}}]}